Samuel M. Alaish

Samuel M. Alaish

Auto-generated profile, based on publicly available information

Samuel M. Alaish

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, United States of America

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2018 in The Journal of Pediatrics
Verified
Journal Article
Closed access
DSDarla R. Shores
Darla R. Shores
SASamuel M. Alaish
Samuel M. Alaish
SASusan W. Aucott
Susan W. Aucott
JBJanine E. Bullard
Janine E. Bullard
CHCourtney Haney
Courtney Haney
KSKathleen B. Schwarz
Kathleen B. Schwarz

1 January 2022 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
AMAbigail E Martin
Abigail E Martin
CMChristian S McEvoy
Christian S McEvoy
KLKimberly Lumpkins
Kimberly Lumpkins
SSStefan Scholz
Stefan Scholz
ADAnthony L DeRoss
Anthony L DeRoss
SDStephen P Dunn
Stephen P Dunn

1 March 2009 in Journal of Pediatric Surgery
Verified
Journal Article
Closed access
SASamuel M. Alaish
Samuel M. Alaish
JGJose Greenspon
Jose Greenspon
ESEric D. Strauch
Eric D. Strauch
CSChen-Chih Sun
Chen-Chih Sun

17 February 2021
Verified
Book Chapter
Closed access
PDF file
RBRoss Beckman
Ross Beckman
SASamuel Alaish
Samuel Alaish
Short bowel syndrome is a common complication following lifesaving intestinal resection for NEC and results in an inability of the child to absorb adequate enteral nutrients to sustain growth. The advent of parenteral nutrition in the 1960s changed what was previously a universally fatal diagnosis to a chronic treatable condition, and our understanding of the disease process and management strategies have evolved considerably over the ensuing decades. While parenteral nutrition remains the mainstay of nutritional support in the early stages, the goal of care is to facilitate intestinal adaptation in order to achieve enteral autonomy, while minimizing complications such as intestinal failure–associated liver disease, central line–associated bloodstream infections, intestinal dysbiosis, and sepsis. Early enteral feed initiation with protocolized advancement is critical, and a variety of pharmaceutical and surgical adjunctive therapies are now available to increase the absorptive capacity of the bowel and minimize complications. Multidisciplinary intestinal rehabilitation programs bring together specialists across disciplines to work collaboratively and achieve improved outcomes. As our understanding of the pathophysiology of short bowel syndrome continues to evolve, new therapeutic options, such as drugs targeted to augment intestinal adaptation and tissue-engineered bowel, have tremendous potential to improve outcomes and quality of life for these challenging patients.